Author

Tim Helbing

Justus-Liebig-Universität Gießen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anna C. AschenbrenneriD· 1 shared Arik HorneiD· 1 shared Barbara GattoiD· 1 shared Caterina CarraroiD· 1 shared Joachim Ludwig SchultzeiD· 1 shared Jonas Schulte-SchreppingiD· 1 shared Kristian HändleriD· 1 shared Lorenzo BonaguroiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Anna C. AschenbrennerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Decoding mechanism of action and susceptibility to drug candidates from integrated transcriptome and chromatin state

Caterina Carraro, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Arik Horne, Marie Oestreich, Stefanie Warnat‐Herresthal, Tim Helbing, Michele De Franco, Kristian Händler, Sach Mukherjee, Thomas Ulas, Valentina Gandin, Richard Goettlich, Anna C. Aschenbrenner, Joachim Ludwig Schultze, Barbara Gatto

This paper integrates transcriptome and chromatin state data to develop a scalable pipeline for drug discovery, predicting cancer cell line sensitivity and guiding compound development.

eLife · Aug 16, 2022Peer-reviewedSystems Biology